Skip to main content
Figure 3 | Critical Care

Figure 3

From: Circulating soluble urokinase plasminogen activator receptor is stably elevated during the first week of treatment in the intensive care unit and predicts mortality in critically ill patients

Figure 3

Sequential measurements of suPAR serum concentrations during the first week of intensive care treatment. (A) Serum suPAR levels were assessed at admission (Day 1), at Day 3 and Day 7 in all critically ill patients. Overall, serum suPAR concentrations did not significantly change during the course of disease within the first week after admission to the ICU (Wilcoxon-Test). (B) In subgroup analyses for sepsis and non-sepsis patients as well, no significant changes of suPAR serum levels within the first week of ICU treatment could be detected.

Back to article page

Critical Care

ISSN: 1364-8535